Demyelination is the pathological stripping, destruction, or loss of myelin — the multilayered lipid-protein sheath produced by oligodendrocytes in the CNS and Schwann cells in the PNS — from the axons it insulates and supports. Myelin functions as both an electrical insulator and a metabolic support structure for axons; its loss dramatically slows or completely blocks saltatory conduction of nerve impulses along affected fibers, producing functional deficits proportional to the location and severity of myelin damage. The resulting neurological impairments span an enormous clinical spectrum depending on which neural pathways are affected: motor deficits, sensory disturbances, visual loss, cognitive dysfunction, ataxia, autonomic dysregulation, and more. Demyelination is the unifying pathologic mechanism shared by a diverse group of diseases — collectively called demyelinating diseases — which are traditionally divided into myelinoclastic disorders (in which normally formed myelin is destroyed by immune attack, toxic injury, or ischemia) and dysmyelinating / leukodystrophic disorders (in which myelin is inherently abnormal due to metabolic or genetic defects). As an inpatient profee coder, demyelination itself is not a standalone ICD-10-CM billable code — it is the mechanism that drives a specific disease-level code. Your job is to identify which demyelinating disease is documented: G35.x (MS — now fully expanded in FY2026), G36.x (acute disseminated demyelination including NMO/Devic), G37.x (other CNS demyelinating diseases including MOGAD G37.81, Balo’s concentric sclerosis G37.5, and central pontine myelinolysis G37.2), or a peripheral demyelinating disorder like GBS (G61.0) or CIDP (G61.81). Demyelination documented without a specific disease etiology maps to G37.9.
”Removal of / reversal / loss” — indicates the stripping away or undoing of the named substance or structure
myel-
Ancient Greek μυελός (myelos)
“Marrow / spinal cord” — the Greek root originally referred to bone marrow and spinal cord; in modern medicine it specifically denotes the myelin sheath of nerve fibers
-in
Latin/French chemical suffix
”Substance” — chemical/biological suffix denoting a lipid or protein compound; myelin = the lipid-rich insulating compound surrounding axons
-ation
Latin verbal noun suffix -atio
”Process / action of” — converts the verb demyelinate into a noun denoting the act or process of myelin loss
The word myelin was coined by German pathologist Rudolf Virchow in 1854, derived from the Ancient Greek μυελός (myelos, “marrow”) because the fatty white substance sheathing nerve fibers bore visual resemblance to the white of bone marrow. The prefix de- (Latin: away, removal of) was later affixed to form the verb demyelinate and noun demyelination in the late 19th and early 20th centuries as neuropathologists characterized the diseases causing myelin loss. The combining form myel- remains one of the most productive roots in neurology, yielding myelopathy, myelitis, myeloma, myelin, poliomyelitis, and the imaging prefix MRI myelography. The root should not be confused with myos- (muscle) — a distinction that is critical for accurate medical terminology and coding alike.
🔀 ALIASES / ALTERNATE TERMS
Demyelinating disease(umbrella term for all conditions characterized by myelin destruction or loss)
Demyelinating disorder(clinical synonym — same scope)
Myelinoclastic disease(classically formed myelin is destroyed by external insult — immune attack, toxin, ischemia)
Dysmyelination / Leukodystrophy(myelin is formed abnormally due to genetic/metabolic defect — Krabbe, metachromatic leukodystrophy, adrenoleukodystrophy)
White matter disease(radiologic descriptor for CNS demyelinating lesions; includes vascular and inflammatory subtypes)
Leukoencephalopathy(disease of the white matter — broader term that includes demyelinating and non-demyelinating etiologies)
ADEM(Acute Disseminated Encephalomyelitis — monophasic inflammatory demyelination post-infection or vaccination)
NMO / Devic disease(Neuromyelitis Optica — anti-AQP4 antibody-mediated demyelination of optic nerves and spinal cord)
Osmotic demyelination syndrome (ODS)(broader term encompassing CPM and extrapontine myelinolysis)
🔗 RELATED TERMS
Myelin — the lipid-rich multilayered sheath produced by oligodendrocytes (CNS) and Schwann cells (PNS); primary target in demyelinating disease
Oligodendrocyte — CNS glial cell responsible for producing and maintaining myelin around multiple axons simultaneously
Schwann cell — PNS equivalent of the oligodendrocyte; each Schwann cell myelinates one axon segment
Axon — the nerve fiber projection along which electrical impulses travel; demyelination slows or blocks conduction; severe disease causes secondary axonal loss
Saltatory conduction — the mechanism by which action potentials “jump” between nodes of Ranvier in myelinated fibers, enabling rapid signal transmission; abolished by demyelination
Plaque — focal area of demyelination and gliosis in the CNS; the histopathologic and MRI unit of MS and related demyelinating diseases
Node of Ranvier — gaps in the myelin sheath where ion exchange occurs during signal propagation; demyelination disrupts this mechanism
Optic neuritis — inflammation and demyelination of the optic nerve; hallmark presentation of MS, NMO, and MOGAD; coded H46.11/H46.12
Transverse myelitis — acute demyelinating inflammation of the spinal cord; cord lesion producing weakness, sensory loss, and bladder dysfunction; coded G37.3
ADEM (Acute Disseminated Encephalomyelitis) — monophasic inflammatory demyelination typically post-viral or post-vaccination; coded G36.9 or G36.8
PLEX — therapeutic plasma exchange removing pathogenic antibodies; used in NMO relapses, GBS, CIDP, severe ADEM
CODING CORNER
🏥 ICD-10-CM CODES
CNS Demyelinating Diseases — Block G35-G37
(Chapter 6: Diseases of the Nervous System — G35-G37 = Demyelinating Diseases of the CNS)(⚠️ Demyelination alone is NOT a billable code — always assign the specific disease-level code)
Multiple Sclerosis — Category G35
(⚠️ FY2026: G35 parent is no longer billable — must use subcategory)
Acute disseminated demyelination, unspecified (ADEM NOS — use when post-infectious/post-vaccination CNS demyelination is documented without further specification)
Other CNS Demyelinating Diseases — Category G37
(G37 parent is NOT billable — includes important FY2026 new code for MOGAD)
Standardized cognitive performance testing per hour (neuropsychological testing for cognitive demyelination in MS/ADEM)
⚠️ Coding Note:Demyelination is a mechanism, not a billable ICD-10-CM code — always assign the specific disease-level code. The most important FY2026 addition to this category is G37.81 (MOGAD) — myelin oligodendrocyte glycoprotein antibody disease is now its own distinct code after years of being buried in G36.8 or G37.89. Any chart documenting anti-MOG IgG positivity with a demyelinating phenotype (optic neuritis, myelitis, cortical encephalitis) should now map to G37.81, not a G35.x MS code. G36.0 (NMO/Devic) carries an Excludes1 from G35 — it cannot be coded alongside any G35.x MS code; these are distinct entities with different serology, treatment, and prognosis. G37.2 (central pontine myelinolysis) requires a cause code — osmotic demyelination is almost always precipitated by rapid sodium correction in hyponatremia; the underlying electrolyte disorder should be sequenced first. For PNS demyelination, G61.0 (GBS) is an MCC and is frequently the principal diagnosis driving ICU-level admissions with mechanical ventilation — ensure plasmapheresis (36514) and IVIG (96365-96366) are fully captured on the profee claim. G61.81 (CIDP) is a CC and is commonly seen on complex neurology and infusion admissions — IVIG is the standard recurring treatment and each infusion encounter should have separately billed 96365 + 96366 add-on hours. For NCS/EMG: nerve conduction studies (95907-95913) and needle EMG (95860-95864) are separately billable but must be performed and interpreted by the same provider on the same date — don’t let the bundle rules catch you; verify documentation supports both components.